Cost-effectiveness of guanfacine extended-release versus atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder in Canada
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1250
https://www.valueinhealthjournal.com/article/S1098-3015(14)01301-1/fulltext
Title :
Cost-effectiveness of guanfacine extended-release versus atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01301-1&doi=10.1016/j.jval.2014.03.1250
First page :
A213
Section Title :
Mental Health
Open access? :
No
Section Order :
710